Biotech

All Articles

Zephyrm seeks Hong Kong IPO to cash stage 3 tissue treatment tests

.Zephyrm Bioscience is gusting toward the Hong Kong stock exchange, filing (PDF) for an IPO to bankr...

Frazier Life Sciences collects $630M for tiny, mid-cap biotechs

.Frazier Everyday life Sciences has actually sourced a further $630 million for its fund paid attent...

GigaGen gathers around $135M BARDA bucks to beat botulism

.Antibody connoisseur GigaGen, a subsidiary of Spanish biopharma Grifols, is ramping up its own tech...

GPCR firm Septerna apply for IPO on durability of preclinical information

.Septerna will figure out how a biotech without "any kind of relevant clinical data" meals in the ov...

Kurma shuts initially $154M loot for largest biotech fund as yet

.International VC organization Kurma Allies has actually unveiled its own most up-to-date biotech fu...

Prothena advertises one director while one more leaves-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of considerable management hirings, firings ...

Editas exploit Vertex Cas9 licensing liberties for $57M

.Versus the backdrop of a Cas9 patent struggle that rejects to perish, Editas Medicine is actually c...

Ultragenyx fine-tunes gene therapy dosing to call up effectiveness

.A minority of individuals taking Ultragenyx Drug's Wilson ailment genetics treatment UX701 have gon...

Biopharma discharge rate stabilizes in Q3: Tough Biotech study

.As summer months warmth turns to cool winds, wishes that this year will deliver extensive sector re...

J &amp J drops stage 2 dengue candidate in most recent switch from vaccines

.Johnson &amp Johnson's deprioritization of its contagious illness pipeline has actually claimed an ...